An Interview with Feng Zhang

Sarah Zhang, The Atlantic, 07 June 2018,

Feng Zhang recently took a break from CrisprCon to talk with The Atlantic about his journey with CRISPR and where it could be going.  Zhang states that many people email him wanting to know if the technology can help cure themselves or a loved one, and while he understands their position, he cautions that we shouldn’t screw up this opportunity by rushing the technology.

Author: Advanced Analytical

Advanced Analytical Technologies, Inc. (AATI) simplifies complex genomics workflows to accelerate research and discovery in pharmaceuticals, life science, biofuels, biotechnology and healthcare.

Leave a Reply